ARTICLE | Company News
Altea, KAI deal
January 25, 2010 8:00 AM UTC
The companies will use Altea's PassPort Transdermal Delivery System to co-develop three undisclosed protein kinase C (PKC) inhibitors from KAI to treat pain, hyperparathyroidism and a potential third...